The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
Abstract
BACKGROUND: Detection of asymptomatic ischemia in patients with coronary artery disease has been associated with increased risk for adverse outcome, but treatment of patients with asymptomatic ischemia remains controversial. Accordingly, the purpose of this study was to determine if treatment reduces adverse outcome in patients with daily life ischemia. METHODS AND RESULTS: A multicenter, randomized, double-blind, placebo-controlled study of asymptomatic or minimally symptomatic outpatients with daily life silent ischemia due to coronary artery disease was conducted. The primary outcome measure was event-free survival at 1 year by Kaplan-Meier analysis. Events were death, resuscitated ventricular tachycardia/fibrillation, myocardial infarction, hospitalization for unstable angina, aggravation of angina, or revascularization. The secondary outcome was ischemia during ambulatory ECG monitoring at 4 weeks. Three hundred six outpatients with mild or no angina (Canadian Cardiovascular Society class I or II), abnormal exercise tests, and ischemia on ambulatory monitoring were randomized to receive either atenolol (100 mg/d) or placebo. After 4 weeks of treatment, the number (mean +/- SD, 3.6 +/- 4.2 versus 1.7 +/- 4.6 episodes, P < .001) and average duration (30 +/- 3.3 versus 16.4 +/- 6.7 minutes, P < .001) of ischemic episodes per 48 hours of ambulatory monitoring decreased in atenolol- compared with placebo-assigned patients (4.4 +/- 4.6 to 3.1 +/- 6.0 episodes and 36.6 +/- 4.1 to 30 +/- 5.5 minutes). Event-free survival improved in atenolol-treated patients (P < .0066), who had an increased time to onset of first adverse event (120 versus 79 days) and fewer total first events compared with placebo (relative risk, 0.44; 95% confidence intervals, 0.26 to 0.75; P = .001). There was a nonsignificant trend for fewer serious events (death, resuscitation from ventricular tachycardia/fibrillation, nonfatal myocardial infarction, or hospitalization for unstable angina) in atenolol-treated patients (relative risk, 0.55; 95% confidence intervals, 0.22 to 1.33; P = .175). The most powerful univariate and multivariate correlate of event-free survival was absence of ischemia on ambulatory monitoring at 4 weeks. Side effects were mild and generally similar comparing atenolol- and placebo-treated patients, although bradycardia was more frequent with atenolol. CONCLUSIONS: Atenolol treatment reduced daily life ischemia and was associated with reduced risk for adverse outcome in asymptomatic and mildly symptomatic patients compared with placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transient asymptomatic ST segment depression during daily activity
Schang, S. J., & Fepine, C. J. (1975) · The American Journal of Cardiology · doi:10.1016/0002-9149(75)90776-6 · Cited by 515
Transient ST-segment depression as a marker of myocardial ischemia during daily life
Deanfield, J. E., Shea, M., Ribiero, P., Landsheere, C. M. D., Wilson, R. A., Horlock, P., & Selwyn, A. P. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80066-1 · Cited by 390
Stern, S., & Tzivoni, D. (1974) · Heart · doi:10.1136/hrt.36.5.481 · Cited by 366
Silent ischemia during daily life is an independent predictor of mortality in stable angina.
Deedwania, P. C., & Carbajal, E. V. (1990) · Circulation · doi:10.1161/01.cir.81.3.748 · Cited by 334
Self-citationPrognostic significance of silent myocardial ischemia in patients with unstable angina
Nademanee, K., Intarachot, V., Josephson, M. A., Rieders, D., Mody, F. V., & Singh, B. N. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80152-3 · Cited by 295
Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients
Gottlieb, S. O. (1988) · JAMA · doi:10.1001/jama.259.7.1030 · Cited by 281
Prognostic significance of ischemic episodes in patients with previous myocardial infarction
Tzivoni, D., Gavish, A., Zin, D., Gottlieb, S., Moriel, M., Keren, A., Banai, S., & Stern, S. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91198-8 · Cited by 243
Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina
Gottlieb, S. O., Weisfeldt, M. L., Ouyang, P., Mellits, E. D., & Gerstenblith, G. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80267-x · Cited by 226
Langer, A., Freeman, M. R., & Armstrong, P. W. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90338-0 · Cited by 215
Johnson, S. M., Mauritson, D. R., Winniford, M. D., Willerson, J. T., Firth, B. G., Cary, J. R., & Hillis, L. D. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90522-1 · Cited by 182
Cited by
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
Mangano, D. T., Layug, E. L., Wallace, A., & Tateo, I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352301 · Cited by 1,694
Poldermans, D., Boersma, E., Bax, J. J., Thomson, I. R., van de Ven, L. L. M., Blankensteijn, J. D., Baars, H. F., Yo, T.-I., Trocino, G., Vigna, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412402 · Cited by 1,496
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,336
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361426 · Cited by 661
Metadata
- Authors
- Pepine, C. J., Cohn, P. F., Deedwania, P. C., Gibson, R. S., Handberg, E., Hill, J. A., Miller, E., Marks, R. G., & Thadani, U.
- Venue
- Circulation
- Published
- 1994-08
- Volume
- 90
- Issue
- 2
- Pages
- 762-768
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2016354423
- Cited by
- 339
- References
- 23
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). https://app.cochat.ai/papers/10.1161/01.cir.90.2.762
- The paper
- Pepine, C. J., Cohn, P. F., Deedwania, P. C., Gibson, R. S., Handberg, E., Hill, J. A., Miller, E., Marks, R. G., & Thadani, U. (1994). Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation. https://doi.org/10.1161/01.cir.90.2.762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.